1,734 reports of this reaction
2.3% of all CICLESONIDE reports
#7 most reported adverse reaction
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is the #7 most commonly reported adverse reaction for CICLESONIDE, manufactured by Covis Pharma US, Inc. There are 1,734 FDA adverse event reports linking CICLESONIDE to LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES. This represents approximately 2.3% of all 74,022 adverse event reports for this drug.
Patients taking CICLESONIDE who experience loss of personal independence in daily activities should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is a less commonly reported adverse event for CICLESONIDE, but still significant enough to appear in the safety profile.
In addition to loss of personal independence in daily activities, the following adverse reactions have been reported for CICLESONIDE:
The following drugs have also been linked to loss of personal independence in daily activities in FDA adverse event reports:
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES has been reported as an adverse event in 1,734 FDA reports for CICLESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES accounts for approximately 2.3% of all adverse event reports for CICLESONIDE, making it a notable side effect.
If you experience loss of personal independence in daily activities while taking CICLESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.